Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results

Kuhnt, T. and Schreiber, A. and Pirnasch, A. and Hautmann, M. G. and Hass, P. and Sieker, F. P. and Engenhart-Cabilic, R. and Richter, M. and Dellas, K. and Dunst, J. (2016) Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results. ANNALS OF ONCOLOGY, 27 (Suppl6). vi347. ISSN 0923-7534, 1569-8041

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Petra Gürster
Date Deposited: 27 Aug 2020 10:52
Last Modified: 27 Aug 2020 10:52
URI: https://pred.uni-regensburg.de/id/eprint/4120

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.